What is IBC?
A working definition
Inflammatory Breast Cancer (IBC) is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast.
This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or “inflamed.” Read More
How Do We Help?
We attend research meetings, serve on grant committee’s, lobby, educate and run online support groups, just to list a few ways we spend our time.
However, we want you to also see we are about funding research because we feel that is where the rubber meets the road.
The purpose of The IBC Network Foundation is simple:
- To fund research regarding Inflammatory Breast Cancer.
- To provide an avenue to network proactive education to the general population as well as the medical community regarding Inflammatory Breast Cancer.
The IBC Network Foundation’s own Terry Arnold was named one of Houston’s 50 Most Influential Women of 2017 by Houston Woman Magazine.
Click here to see a complete list of 2017 honorees.
I’m extremely grateful and honored to be selected as one of Houston’s 50 Most Influential Women of 2017. This award is sponsored by Houston Woman Magazine, and I have heard and read about this honor in the past and would have never in a million years thought that I one day would be in that pool of women. I’m extremely grateful for Beverly Denver’s support.
Hope always,
Terry Lynn Arnold
Founder of The IBC Network Foundation
IBC Education
“Because Research Matters” T-SHIRTS are available!
We hope you will join us as we put our message out to the world.
Because Research Matters
We think this simple message sums up our mission well. Awareness is important and we know that IBC education is an area that needs improvement globally, but without research, how can we expect to see better for women and men who currently have IBC? Research funding is key.
Featured News
Recent News
FEATURED ARTICLE
6th International Inflammatory Breast Cancer Symposium Will Be Held in Spain
New Concepts in the Biology and Management of Aggressive Breast Cancers is the theme of the 6th International Inflammatory Breast Cancer Symposium to be held in Madrid, Spain on September 20 – 21, 2018.
These experts will review evidence and published literature and provide a perspective in the use of novel diagnostics (e.g. liquid biopsy) and therapeutics in the endocrine resistance setting, TNBC and inflammatory breast cancer, a rare but, aggressive and deadly form of breast cancer.
